NCT02403063View on ClinicalTrials.gov

Electromyographic Activity of the Respiratory Muscles During Neostigmine or Sugammadex Enhanced Recovery After Neuromuscular Blockade

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

November 30, 2015

Conditions
Respiratory MusclesElectromyography
Interventions
DRUG

Sugammadex

Administration of sugammadex 2mg/kg for enhanced recovery after neuromuscular blockade with rocuronium

DRUG

Neostigmine

Administration of neostigmine 50µg/kg for enhanced recovery after neuromuscular blockade with rocuronium

DRUG

Neostigmine-sugammadex

Administration of neostigmine 50µg/kg followed 3 minutes later by administration of sugammadex 2mg/kg for enhanced recovery after neuromuscular blockade with rocuronium

Trial Locations (1)

9300

OLV Hospital, Aalst

All Listed Sponsors
lead

Onze Lieve Vrouw Hospital

OTHER

NCT02403063 - Electromyographic Activity of the Respiratory Muscles During Neostigmine or Sugammadex Enhanced Recovery After Neuromuscular Blockade | Biotech Hunter | Biotech Hunter